Y-mAbs

Y-mAbs is a clinical biopharmaceutical company at the commercial stage, focusing on the development and commercialization of novel antibody-based therapeutic products for cancer treatment. We possess a broad and advanced pipeline, including pivotal-stage product candidates targeting a range of objectives. Our mission is to become a global leader in developing better and safer antibody-based oncology products to address significant unmet medical needs in both pediatric and adult patients. Through the right partnerships and collaborations, we envision transforming the course and outcomes of cancer treatment.